{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T03:27:13Z","timestamp":1792985233736,"version":"4.5.0"},"reference-count":163,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,8,12]],"date-time":"2015-08-12T00:00:00Z","timestamp":1439337600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,8,12]],"date-time":"2015-08-12T00:00:00Z","timestamp":1439337600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R21 NS078226"],"award-info":[{"award-number":["R21 NS078226"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 NS075212"],"award-info":[{"award-number":["R01 NS075212"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 AI27767"],"award-info":[{"award-number":["P30 AI27767"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s00401-015-1466-4","type":"journal-article","created":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T11:34:15Z","timestamp":1439292855000},"page":"445-468","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":80,"title":["Inflammatory neuropathies: pathology, molecular markers and targets for specific therapeutic intervention"],"prefix":"10.1007","volume":"130","author":[{"given":"Eroboghene E.","family":"Ubogu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,12]]},"reference":[{"key":"1466_CR1","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1161\/01.RES.0000255691.76142.4a","volume":"100","author":"WC Aird","year":"2007","unstructured":"Aird WC (2007) Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res 100:158\u2013173. doi:\n                    10.1161\/01.RES.0000255691.76142.4a","journal-title":"Circ Res"},{"key":"1466_CR2","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1161\/01.RES.0000255690.03436.ae","volume":"100","author":"WC Aird","year":"2007","unstructured":"Aird WC (2007) Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 100:174\u2013190. doi:\n                    10.1161\/01.RES.0000255690.03436.ae","journal-title":"Circ Res"},{"key":"1466_CR3","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/S0165-5728(01)00306-X","volume":"116","author":"B Andorfer","year":"2001","unstructured":"Andorfer B, Kieseier BC, Mathey E, Armati P, Pollard J, Oka N, Hartung HP (2001) Expression and distribution of transcription factor NF-kappaB and inhibitor IkappaB in the inflamed peripheral nervous system. J Neuroimmunol 116:226\u2013232","journal-title":"J Neuroimmunol"},{"key":"1466_CR4","first-page":"667","volume":"70","author":"JJ Archelos","year":"1994","unstructured":"Archelos JJ, Maurer M, Jung S, Miyasaka M, Tamatani T, Toyka KV, Hartung HP (1994) Inhibition of experimental autoimmune neuritis by an antibody to the lymphocyte function-associated antigen-1. Lab Invest 70:667\u2013675","journal-title":"Lab Invest"},{"key":"1466_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/00005792-196905000-00001","volume":"48","author":"AK Asbury","year":"1969","unstructured":"Asbury AK, Arnason BG, Adams RD (1969) The inflammatory lesion in idiopathic polyneuritis. Its role in pathogenesis. Medicine 48:173\u2013215","journal-title":"Medicine"},{"issue":"Suppl","key":"1466_CR6","doi-asserted-by":"publisher","first-page":"S21","DOI":"10.1002\/ana.410270707","volume":"27","author":"AK Asbury","year":"1990","unstructured":"Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain\u2013Barre syndrome. Ann Neurol 27(Suppl):S21\u2013S24","journal-title":"Ann Neurol"},{"key":"1466_CR7","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1001\/archneur.1992.00530360079021","volume":"49","author":"S Bansil","year":"1992","unstructured":"Bansil S, Mithen FA, Singhal BS, Cook SD, Rohowsky-Kochan C (1992) Elevated neopterin levels in Guillain\u2013Barre syndrome. Further evidence of immune activation. Arch Neurol 49:1277\u20131280","journal-title":"Arch Neurol"},{"key":"1466_CR8","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1002\/mus.24164","volume":"50","author":"CE Bekircan-Kurt","year":"2014","unstructured":"Bekircan-Kurt CE, Uceyler N, Sommer C (2014) Cutaneous activation of rage in nonsystemic vasculitic and diabetic neuropathy. Muscle Nerve 50:377\u2013383. doi:\n                    10.1002\/mus.24164","journal-title":"Muscle Nerve"},{"key":"1466_CR9","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1136\/ard.2005.035295","volume":"65","author":"C Belizna","year":"2006","unstructured":"Belizna C, Duijvestijn A, Hamidou M, Tervaert JW (2006) Antiendothelial cell antibodies in vasculitis and connective tissue disease. Ann Rheum Dis 65:1545\u20131550. doi:\n                    10.1136\/ard.2005.035295","journal-title":"Ann Rheum Dis"},{"key":"1466_CR10","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jneuroim.2013.12.007","volume":"267","author":"S Blum","year":"2014","unstructured":"Blum S, Csurhes P, Reddel S, Spies J, McCombe P (2014) Killer immunoglobulin-like receptor and their HLA ligands in Guillain\u2013Barre Syndrome. J Neuroimmunol 267:92\u201396. doi:\n                    10.1016\/j.jneuroim.2013.12.007","journal-title":"J Neuroimmunol"},{"key":"1466_CR11","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/jns5.12074","volume":"19","author":"S Blum","year":"2014","unstructured":"Blum S, McCombe PA (2014) Genetics of Guillain-Barre syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): current knowledge and future directions. J Peripher Nerv Syst 19:88\u2013103. doi:\n                    10.1111\/jns5.12074","journal-title":"J Peripher Nerv Syst"},{"key":"1466_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1212\/WNL.56.1.74","volume":"56","author":"WM Bosboom","year":"2001","unstructured":"Bosboom WM, Van den Berg LH, Mollee I, Sasker LD, Jansen J, Wokke JH, Logtenberg T (2001) Sural nerve T-cell receptor Vbeta gene utilization in chronic inflammatory demyelinating polyneuropathy and vasculitic neuropathy. Neurology 56:74\u201381","journal-title":"Neurology"},{"key":"1466_CR13","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1212\/WNL.52.3.498","volume":"52","author":"C Bouchard","year":"1999","unstructured":"Bouchard C, Lacroix C, Plante V, Adams D, Chedru F, Guglielmi JM, Said G (1999) Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology 52:498\u2013503","journal-title":"Neurology"},{"key":"1466_CR14","first-page":"19","volume":"6","author":"C Brechenmacher","year":"1987","unstructured":"Brechenmacher C, Vital C, Deminiere C, Laurentjoye L, Castaing Y, Gbikpi-Benissan G, Cardinaud JP, Favarel-Garrigues JP (1987) Guillain\u2013Barre syndrome: an ultrastructural study of peripheral nerve in 65 patients. Clin Neuropathol 6:19\u201324","journal-title":"Clin Neuropathol"},{"key":"1466_CR15","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.1002\/mus.21033","volume":"38","author":"L Broglio","year":"2008","unstructured":"Broglio L, Erne B, Tolnay M, Schaeren-Wiemers N, Fuhr P, Steck AJ, Renaud S (2008) Allograft inflammatory factor-1: a pathogenetic factor for vasculitic neuropathy. Muscle Nerve 38:1272\u20131279. doi:\n                    10.1002\/mus.21033","journal-title":"Muscle Nerve"},{"key":"1466_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1002\/mus.880100310","volume":"10","author":"MJ Brown","year":"1987","unstructured":"Brown MJ, Rosen JL, Lisak RP (1987) Demyelination in vivo by Guillain\u2013Barre syndrome and other human serum. Muscle Nerve 10:263\u2013271. doi:\n                    10.1002\/mus.880100310","journal-title":"Muscle Nerve"},{"key":"1466_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2014.11.022","volume":"278","author":"S Brun","year":"2015","unstructured":"Brun S, Beaino W, Kremer L, Taleb O, Mensah-Nyagan AG, Lam CD, Greer JM, de Seze J, Trifilieff E (2015) Characterization of a new rat model for chronic inflammatory demyelinating polyneuropathies. J Neuroimmunol 278:1\u201310. doi:\n                    10.1016\/j.jneuroim.2014.11.022","journal-title":"J Neuroimmunol"},{"key":"1466_CR18","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1111\/nan.12039","volume":"39","author":"A Brunn","year":"2013","unstructured":"Brunn A, Utermohlen O, Mihelcic M, Sanchez-Ruiz M, Carstov M, Blau T, Ustinova I, Penfold M, Montesinos-Rongen M, Deckert M (2013) Differential effects of CXCR4\u2013CXCL12- and CXCR7\u2013CXCL12-mediated immune reactions on murine P0106-125-induced experimental autoimmune neuritis. Neuropathol Appl Neurobiol 39:772\u2013787. doi:\n                    10.1111\/nan.12039","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1466_CR19","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1002\/prca.200600949","volume":"1","author":"KH Chang","year":"2007","unstructured":"Chang KH, Lyu RK, Tseng MY, Ro LS, Wu YR, Chang HS, Hsu WC, Kuo HC, Huang CC, Chu CC, Hsieh SY, Chen CM (2007) Elevated haptoglobin level of cerebrospinal fluid in Guillain\u2013Barre syndrome revealed by proteomics analysis. Proteomics Clin Appl 1:467\u2013475. doi:\n                    10.1002\/prca.200600949","journal-title":"Proteomics Clin Appl"},{"key":"1466_CR20","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/WCO.0b013e328357a77f","volume":"25","author":"G Chavada","year":"2012","unstructured":"Chavada G, Willison HJ (2012) Autoantibodies in immune-mediated neuropathies. Curr Opin Neurol 25:550\u2013555. doi:\n                    10.1097\/WCO.0b013e328357a77f","journal-title":"Curr Opin Neurol"},{"key":"1466_CR21","unstructured":"Chia L, Fernandez A, Lacroix C, Adams D, Plante V, Said G (1996) Contribution of nerve biopsy findings to the diagnosis of disabling neuropathy in the elderly. A retrospective review of 100 consecutive patients. Brain 119 (Pt 4):1091\u20131098"},{"key":"1466_CR22","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1002\/mus.23829","volume":"48","author":"S Chiang","year":"2013","unstructured":"Chiang S, Ubogu EE (2013) The role of chemokines in Guillain-Barre syndrome. Muscle Nerve 48:320\u2013330. doi:\n                    10.1002\/mus.23829","journal-title":"Muscle Nerve"},{"key":"1466_CR23","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.ncl.2013.01.007","volume":"31","author":"MP Collins","year":"2013","unstructured":"Collins MP, Arnold WD, Kissel JT (2013) The neuropathies of vasculitis. Neurol Clin 31:557\u2013595. doi:\n                    10.1016\/j.ncl.2013.01.007","journal-title":"Neurol Clin"},{"key":"1466_CR24","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1111\/j.1529-8027.2010.00281.x","volume":"15","author":"MP Collins","year":"2010","unstructured":"Collins MP, Dyck PJ, Gronseth GS, Guillevin L, Hadden RD, Heuss D, Leger JM, Notermans NC, Pollard JD, Said G, Sobue G, Vrancken AF, Kissel JT, Peripheral Nerve S (2010) Peripheral Nerve Society Guideline on the classification, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst 15:176\u2013184. doi:\n                    10.1111\/j.1529-8027.2010.00281.x","journal-title":"J Peripher Nerv Syst"},{"key":"1466_CR25","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1002\/mus.21639","volume":"42","author":"MP Collins","year":"2010","unstructured":"Collins MP, Periquet-Collins I, Sahenk Z, Kissel JT (2010) Direct immunofluoresence in vasculitic neuropathy: specificity of vascular immune deposits. Muscle Nerve 42:62\u201369. doi:\n                    10.1002\/mus.21639","journal-title":"Muscle Nerve"},{"key":"1466_CR26","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.bbadis.2014.06.013","volume":"1852","author":"MC Dalakas","year":"2015","unstructured":"Dalakas MC (2015) Pathogenesis of immune-mediated neuropathies. Biochim Biophys Acta 1852:658\u2013666. doi:\n                    10.1016\/j.bbadis.2014.06.013","journal-title":"Biochim Biophys Acta"},{"key":"1466_CR27","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/nrneurol.2011.121","volume":"7","author":"MC Dalakas","year":"2011","unstructured":"Dalakas MC, Medscape (2011) Advances in the diagnosis, pathogenesis and treatment of CIDP. Nat Rev Neurol 7:507\u2013517. doi:\n                    10.1038\/nrneurol.2011.121","journal-title":"Nat Rev Neurol"},{"key":"1466_CR28","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1111\/j.1468-1331.2008.02261.x","volume":"15","author":"H Deng","year":"2008","unstructured":"Deng H, Yang X, Jin T, Wu J, Hu LS, Chang M, Sun XJ, Adem A, Winblad B, Zhu J (2008) The role of IL-12 and TNF-alpha in AIDP and AMAN. Eur J Neurol 15:1100\u20131105. doi:\n                    10.1111\/j.1468-1331.2008.02261.x","journal-title":"Eur J Neurol"},{"key":"1466_CR29","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1111\/j.1529-8027.2012.00372.x","volume":"17","author":"JJ Devaux","year":"2012","unstructured":"Devaux JJ, Odaka M, Yuki N (2012) Nodal proteins are target antigens in Guillain\u2013Barre syndrome. J Peripher Nerv Syst 17:62\u201371. doi:\n                    10.1111\/j.1529-8027.2012.00372.x","journal-title":"J Peripher Nerv Syst"},{"key":"1466_CR30","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1007\/s11940-013-0231-z","volume":"15","author":"MM Dimachkie","year":"2013","unstructured":"Dimachkie MM, Barohn RJ (2013) Guillain\u2013barre syndrome. Curr Treat Options Neurol 15:338\u2013349. doi:\n                    10.1007\/s11940-013-0231-z","journal-title":"Curr Treat Options Neurol"},{"key":"1466_CR31","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.nbd.2004.04.007","volume":"16","author":"RS Duan","year":"2004","unstructured":"Duan RS, Chen Z, Bao L, Quezada HC, Nennesmo I, Winblad B, Zhu J (2004) CCR5 deficiency does not prevent P0 peptide 180-199 immunized mice from experimental autoimmune neuritis. Neurobiol Dis 16:630\u2013637. doi:\n                    10.1016\/j.nbd.2004.04.007","journal-title":"Neurobiol Dis"},{"key":"1466_CR32","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1111\/j.1600-0404.1993.tb05515.x","volume":"87","author":"A Engelhardt","year":"1993","unstructured":"Engelhardt A, Lorler H, Neundorfer B (1993) Immunohistochemical findings in vasculitic neuropathies. Acta Neurol Scand 87:318\u2013321","journal-title":"Acta Neurol Scand"},{"key":"1466_CR33","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.clineuro.2014.03.014","volume":"121","author":"N Fekih-Mrissa","year":"2014","unstructured":"Fekih-Mrissa N, Mrad M, Riahi A, Sayeh A, Zaouali J, Gritli N, Mrissa R (2014) Association of HLA-DR\/DQ polymorphisms with Guillain-Barre syndrome in Tunisian patients. Clin Neurol Neurosurg 121:19\u201322. doi:\n                    10.1016\/j.clineuro.2014.03.014","journal-title":"Clin Neurol Neurosurg"},{"key":"1466_CR34","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1093\/brain\/awt285","volume":"137","author":"C Fokke","year":"2014","unstructured":"Fokke C, van den Berg B, Drenthen J, Walgaard C, van Doorn PA, Jacobs BC (2014) Diagnosis of Guillain\u2013Barre syndrome and validation of Brighton criteria. Brain 137:33\u201343. doi:\n                    10.1093\/brain\/awt285","journal-title":"Brain"},{"key":"1466_CR35","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1212\/01.WNL.0000143055.09646.31","volume":"63","author":"K Geleijns","year":"2004","unstructured":"Geleijns K, Brouwer BA, Jacobs BC, Houwing-Duistermaat JJ, van Duijn CM, van Doorn PA (2004) The occurrence of Guillain\u2013Barre syndrome within families. Neurology 63:1747\u20131750","journal-title":"Neurology"},{"issue":"Suppl","key":"1466_CR36","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1002\/ana.410270717","volume":"27","author":"JW Griffin","year":"1990","unstructured":"Griffin JW, Stoll G, Li CY, Tyor W, Cornblath DR (1990) Macrophage responses in inflammatory demyelinating neuropathies. Ann Neurol 27(Suppl):S64\u2013S68","journal-title":"Ann Neurol"},{"key":"1466_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(13)70236-9","volume":"13","author":"KG Gwathmey","year":"2014","unstructured":"Gwathmey KG, Burns TM, Collins MP, Dyck PJ (2014) Vasculitic neuropathies. Lancet Neurol 13:67\u201382. doi:\n                    10.1016\/S1474-4422(13)70236-9","journal-title":"Lancet Neurol"},{"key":"1466_CR38","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1046\/j.1365-2990.2002.00421.x","volume":"28","author":"RD Hadden","year":"2002","unstructured":"Hadden RD, Gregson NA, Gold R, Smith KJ, Hughes RA (2002) Accumulation of immunoglobulin across the \u2018blood\u2013nerve barrier\u2019 in spinal roots in adoptive transfer experimental autoimmune neuritis. Neuropathol Appl Neurobiol 28:489\u2013497","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1466_CR39","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/S0165-5728(01)00390-3","volume":"119","author":"RD Hadden","year":"2001","unstructured":"Hadden RD, Gregson NA, Gold R, Willison HJ, Hughes RA (2001) Guillain-Barre syndrome serum and anti-Campylobacter antibody do not exacerbate experimental autoimmune neuritis. J Neuroimmunol 119:306\u2013316","journal-title":"J Neuroimmunol"},{"key":"1466_CR40","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/ana.410390512","volume":"39","author":"CE Hafer-Macko","year":"1996","unstructured":"Hafer-Macko CE, Sheikh KA, Li CY, Ho TW, Cornblath DR, McKhann GM, Asbury AK, Griffin JW (1996) Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol 39:625\u2013635. doi:\n                    10.1002\/ana.410390512","journal-title":"Ann Neurol"},{"key":"1466_CR41","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1002\/ana.410310416","volume":"31","author":"SM Hall","year":"1992","unstructured":"Hall SM, Hughes RA, Atkinson PF, McColl I, Gale A (1992) Motor nerve biopsy in severe Guillain\u2013Barre syndrome. Ann Neurol 31:441\u2013444. doi:\n                    10.1002\/ana.410310416","journal-title":"Ann Neurol"},{"key":"1466_CR42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1007\/s10875-013-9965-3","volume":"34","author":"RK Han","year":"2014","unstructured":"Han RK, Cheng YF, Zhou SS, Guo H, He RD, Chi LJ, Zhang LM (2014) Increased circulating Th17 cell populations and elevated CSF osteopontin and IL-17 concentrations in patients with Guillain\u2013Barre syndrome. J Clin Immunol 34:94\u2013103. doi:\n                    10.1007\/s10875-013-9965-3","journal-title":"J Clin Immunol"},{"key":"1466_CR43","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1002\/ana.410150209","volume":"15","author":"BM Harrison","year":"1984","unstructured":"Harrison BM, Hansen LA, Pollard JD, McLeod JG (1984) Demyelination induced by serum from patients with Guillain\u2013Barre syndrome. Ann Neurol 15:163\u2013170. doi:\n                    10.1002\/ana.410150209","journal-title":"Ann Neurol"},{"key":"1466_CR44","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1002\/ana.410300110","volume":"30","author":"HP Hartung","year":"1991","unstructured":"Hartung HP, Reiners K, Schmidt B, Stoll G, Toyka KV (1991) Serum interleukin-2 concentrations in Guillain\u2013Barre syndrome and chronic idiopathic demyelinating polyradiculoneuropathy: comparison with other neurological diseases of presumed immunopathogenesis. Ann Neurol 30:48\u201353. doi:\n                    10.1002\/ana.410300110","journal-title":"Ann Neurol"},{"key":"1466_CR45","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/mus.20039","volume":"29","author":"KM Haslbeck","year":"2004","unstructured":"Haslbeck KM, Bierhaus A, Erwin S, Kirchner A, Nawroth P, Schlotzer U, Neundorfer B, Heuss D (2004) Receptor for advanced glycation endproduct (RAGE)-mediated nuclear factor-kappaB activation in vasculitic neuropathy. Muscle Nerve 29:853\u2013860. doi:\n                    10.1002\/mus.20039","journal-title":"Muscle Nerve"},{"key":"1466_CR46","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1002\/1097-4598(200007)23:7<999::AID-MUS1>3.0.CO;2-I","volume":"23","author":"D Heuss","year":"2000","unstructured":"Heuss D, Probst-Cousin S, Kayser C, Neundorfer B (2000) Cell death in vasculitic neuropathy. Muscle Nerve 23:999\u20131004","journal-title":"Muscle Nerve"},{"key":"1466_CR47","unstructured":"Honavar M, Tharakan JK, Hughes RA, Leibowitz S, Winer JB (1991) A clinicopathological study of the Guillain-Barre syndrome. Nine cases and literature review. Brain 114(Pt 3):1245\u20131269"},{"key":"1466_CR48","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1001\/archneur.63.6.858","volume":"63","author":"W Hu","year":"2006","unstructured":"Hu W, Dehmel T, Pirhonen J, Hartung HP, Kieseier BC (2006) Interleukin 23 in acute inflammatory demyelination of the peripheral nerve. Arch Neurol 63:858\u2013864. doi:\n                    10.1001\/archneur.63.6.858","journal-title":"Arch Neurol"},{"key":"1466_CR49","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1212\/01.wnl.0000250240.99311.9d","volume":"68","author":"W Hu","year":"2007","unstructured":"Hu W, Janke A, Ortler S, Hartung HP, Leder C, Kieseier BC, Wiendl H (2007) Expression of CD28-related costimulatory molecule and its ligand in inflammatory neuropathies. Neurology 68:277\u2013282. doi:\n                    10.1212\/01.wnl.0000250240.99311.9d","journal-title":"Neurology"},{"key":"1466_CR50","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.jneuroim.2008.10.011","volume":"206","author":"YC Huang","year":"2009","unstructured":"Huang YC, Lyu RK, Tseng MY, Chang HS, Hsu WC, Kuo HC, Chu CC, Wu YR, Ro LS, Huang CC, Chen CM (2009) Decreased intrathecal synthesis of prostaglandin D2 synthase in the cerebrospinal fluid of patients with acute inflammatory demyelinating polyneuropathy. J Neuroimmunol 206:100\u2013105. doi:\n                    10.1016\/j.jneuroim.2008.10.011","journal-title":"J Neuroimmunol"},{"key":"1466_CR51","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1002\/mus.880150506","volume":"15","author":"R Hughes","year":"1992","unstructured":"Hughes R, Atkinson P, Coates P, Hall S, Leibowitz S (1992) Sural nerve biopsies in Guillain\u2013Barre syndrome: axonal degeneration and macrophage-associated demyelination and absence of cytomegalovirus genome. Muscle Nerve 15:568\u2013575. doi:\n                    10.1002\/mus.880150506","journal-title":"Muscle Nerve"},{"key":"1466_CR52","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1136\/jnnp.2006.106617","volume":"78","author":"HR Inglis","year":"2007","unstructured":"Inglis HR, Csurhes PA, McCombe PA (2007) Antibody responses to peptides of peripheral nerve myelin proteins P0 and P2 in patients with inflammatory demyelinating neuropathy. J Neurol Neurosurg Psychiatry 78:419\u2013422. doi:\n                    10.1136\/jnnp.2006.106617","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1466_CR53","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0165-5728(00)00460-4","volume":"114","author":"S Jander","year":"2001","unstructured":"Jander S, Stoll G (2001) Interleukin-18 is induced in acute inflammatory demyelinating polyneuropathy. J Neuroimmunol 114:253\u2013258","journal-title":"J Neuroimmunol"},{"key":"1466_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 revised international chapel hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1\u201311. doi:\n                    10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"key":"1466_CR55","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1111\/j.1468-1331.2007.01761.x","volume":"14","author":"T Jin","year":"2007","unstructured":"Jin T, Hu LS, Chang M, Wu J, Winblad B, Zhu J (2007) Proteomic identification of potential protein markers in cerebrospinal fluid of GBS patients. Eur J Neurol 14:563\u2013568. doi:\n                    10.1111\/j.1468-1331.2007.01761.x","journal-title":"Eur J Neurol"},{"key":"1466_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1529-8027.2010.00245.x","volume":"15","author":"Joint Task Force of the E, the PNS","year":"2010","unstructured":"Joint Task Force of the E, the PNS (2010) European Federation of Neurological Societies\/Peripheral Nerve Society Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society\u2014First Revision. J Peripher Nerv Syst 15:1\u20139. doi:\n                    10.1111\/j.1529-8027.2010.00245.x","journal-title":"J Peripher Nerv Syst"},{"key":"1466_CR57","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/jnr.10879","volume":"75","author":"S Jung","year":"2004","unstructured":"Jung S, Gaupp S, Korn T, Kollner G, Hartung HP, Toyka KV (2004) Biphasic form of experimental autoimmune neuritis in dark Agouti rats and its oral therapy by antigen-specific tolerization. J Neurosci Res 75:524\u2013535. doi:\n                    10.1002\/jnr.10879","journal-title":"J Neurosci Res"},{"key":"1466_CR58","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1093\/glycob\/cwp027","volume":"19","author":"K Kaida","year":"2009","unstructured":"Kaida K, Ariga T, Yu RK (2009) Antiganglioside antibodies and their pathophysiological effects on Guillain\u2013Barre syndrome and related disorders\u2014a review. Glycobiology 19:676\u2013692. doi:\n                    10.1093\/glycob\/cwp027","journal-title":"Glycobiology"},{"key":"1466_CR59","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1136\/jnnp.2003.025692","volume":"75","author":"T Kanda","year":"2004","unstructured":"Kanda T, Numata Y, Mizusawa H (2004) Chronic inflammatory demyelinating polyneuropathy: decreased claudin-5 and relocated ZO-1. J Neurol Neurosurg Psychiatry 75:765\u2013769","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1466_CR60","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1212\/01.WNL.0000041494.70178.17","volume":"60","author":"T Kanda","year":"2003","unstructured":"Kanda T, Yamawaki M, Mizusawa H (2003) Sera from Guillain\u2013Barre patients enhance leakage in blood\u2013nerve barrier model. Neurology 60:301\u2013306","journal-title":"Neurology"},{"key":"1466_CR61","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1212\/WNL.34.2.240","volume":"34","author":"RA Kaslow","year":"1984","unstructured":"Kaslow RA, Sullivan-Bolyai JZ, Hafkin B, Schonberger LB, Kraus L, Moore MJ, Yunis E, Williams RM (1984) HLA antigens in Guillain\u2013Barre syndrome. Neurology 34:240\u2013242","journal-title":"Neurology"},{"key":"1466_CR62","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/S0022-510X(98)00121-X","volume":"158","author":"A Khalili-Shirazi","year":"1998","unstructured":"Khalili-Shirazi A, Gregson NA, Londei M, Summers L, Hughes RA (1998) The distribution of CD1 molecules in inflammatory neuropathy. J Neurol Sci 158:154\u2013163","journal-title":"J Neurol Sci"},{"key":"1466_CR63","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1136\/jnnp.69.3.362","volume":"69","author":"R Kiefer","year":"2000","unstructured":"Kiefer R, Dangond F, Mueller M, Toyka KV, Hafler DA, Hartung HP (2000) Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies. J Neurol Neurosurg Psychiatry 69:362\u2013368","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 3","key":"1466_CR64","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1093\/brain\/121.3.469","volume":"121","author":"R Kiefer","year":"1998","unstructured":"Kiefer R, Kieseier BC, Bruck W, Hartung HP, Toyka KV (1998) Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies. Brain 121(Pt 3):469\u2013479","journal-title":"Brain"},{"key":"1466_CR65","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1002\/mus.20076","volume":"30","author":"BC Kieseier","year":"2004","unstructured":"Kieseier BC, Kiefer R, Gold R, Hemmer B, Willison HJ, Hartung HP (2004) Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve 30:131\u2013156. doi:\n                    10.1002\/mus.20076","journal-title":"Muscle Nerve"},{"key":"1466_CR66","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1093\/brain\/awf070","volume":"125","author":"BC Kieseier","year":"2002","unstructured":"Kieseier BC, Tani M, Mahad D, Oka N, Ho T, Woodroofe N, Griffin JW, Toyka KV, Ransohoff RM, Hartung HP (2002) Chemokines and chemokine receptors in inflammatory demyelinating neuropathies: a central role for IP-10. Brain 125:823\u2013834","journal-title":"Brain"},{"key":"1466_CR67","doi-asserted-by":"publisher","first-page":"8753","DOI":"10.4049\/jimmunol.181.12.8753","volume":"181","author":"HJ Kim","year":"2008","unstructured":"Kim HJ, Jung CG, Jensen MA, Dukala D, Soliven B (2008) Targeting of myelin protein zero in a spontaneous autoimmune polyneuropathy. J Immunol 181:8753\u20138760","journal-title":"J Immunol"},{"key":"1466_CR68","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1172\/JCI114152","volume":"84","author":"CL Koski","year":"1989","unstructured":"Koski CL, Chou DK, Jungalwala FB (1989) Anti-peripheral nerve myelin antibodies in Guillain\u2013Barre syndrome bind a neutral glycolipid of peripheral myelin and cross-react with Forssman antigen. J Clin Investig 84:280\u2013287. doi:\n                    10.1172\/JCI114152","journal-title":"J Clin Investig"},{"key":"1466_CR69","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1002\/mus.880120402","volume":"12","author":"DA Krendel","year":"1989","unstructured":"Krendel DA, Parks HP, Anthony DC, St Clair MB, Graham DG (1989) Sural nerve biopsy in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 12:257\u2013264. doi:\n                    10.1002\/mus.880120402","journal-title":"Muscle Nerve"},{"key":"1466_CR70","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/j.1471-4159.2010.07029.x","volume":"116","author":"S Kusunoki","year":"2011","unstructured":"Kusunoki S, Kaida K (2011) Antibodies against ganglioside complexes in Guillain\u2013Barre syndrome and related disorders. J Neurochem 116:828\u2013832. doi:\n                    10.1111\/j.1471-4159.2010.07029.x","journal-title":"J Neurochem"},{"key":"1466_CR71","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1212\/WNL.53.1.62","volume":"53","author":"D Leppert","year":"1999","unstructured":"Leppert D, Hughes P, Huber S, Erne B, Grygar C, Said G, Miller KM, Steck AJ, Probst A, Fuhr P (1999) Matrix metalloproteinase upregulation in chronic inflammatory demyelinating polyneuropathy and nonsystemic vasculitic neuropathy. Neurology 53:62\u201370","journal-title":"Neurology"},{"key":"1466_CR72","doi-asserted-by":"publisher","first-page":"639712","DOI":"10.1155\/2013\/639712","volume":"2013","author":"C Li","year":"2013","unstructured":"Li C, Zhao P, Sun X, Che Y, Jiang Y (2013) Elevated levels of cerebrospinal fluid and plasma interleukin-37 in patients with Guillain-Barre syndrome. Mediators Inflamm 2013:639712. doi:\n                    10.1155\/2013\/639712","journal-title":"Mediators Inflamm"},{"key":"1466_CR73","doi-asserted-by":"publisher","first-page":"260473","DOI":"10.1155\/2012\/260473","volume":"2012","author":"S Li","year":"2012","unstructured":"Li S, Yu M, Li H, Zhang H, Jiang Y (2012) IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain\u2013Barre syndrome. Mediators Inflamm 2012:260473. doi:\n                    10.1155\/2012\/260473","journal-title":"Mediators Inflamm"},{"key":"1466_CR74","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1007\/s00401-003-0689-y","volume":"105","author":"T Lindenlaub","year":"2003","unstructured":"Lindenlaub T, Sommer C (2003) Cytokines in sural nerve biopsies from inflammatory and non-inflammatory neuropathies. Acta Neuropathol 105:593\u2013602. doi:\n                    10.1007\/s00401-003-0689-y","journal-title":"Acta Neuropathol"},{"key":"1466_CR75","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/j.1529-8027.2009.00220.x","volume":"14","author":"F Madia","year":"2009","unstructured":"Madia F, Frisullo G, Nociti V, Conte A, Luigetti M, Del Grande A, Patanella AK, Iorio R, Tonali PA, Batocchi AP, Sabatelli M (2009) pSTAT1, pSTAT3, and T-bet as markers of disease activity in chronic inflammatory demyelinating polyradiculoneuropathy. J Peripher Nerv Syst 14:107\u2013117. doi:\n                    10.1111\/j.1529-8027.2009.00220.x","journal-title":"J Peripher Nerv Syst"},{"key":"1466_CR76","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/0165-5728(93)90284-6","volume":"47","author":"D Maimone","year":"1993","unstructured":"Maimone D, Annunziata P, Simone IL, Livrea P, Guazzi GC (1993) Interleukin-6 levels in the cerebrospinal fluid and serum of patients with Guillain\u2013Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 47:55\u201361","journal-title":"J Neuroimmunol"},{"key":"1466_CR77","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1136\/jnnp.2007.123943","volume":"79","author":"A Makowska","year":"2008","unstructured":"Makowska A, Pritchard J, Sanvito L, Gregson N, Peakman M, Hayday A, Hughes R (2008) Immune responses to myelin proteins in Guillain\u2013Barre syndrome. J Neurol Neurosurg Psychiatry 79:664\u2013671. doi:\n                    10.1136\/jnnp.2007.123943","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1466_CR78","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1750-3639.2007.00067.x","volume":"17","author":"S Man","year":"2007","unstructured":"Man S, Ubogu EE, Ransohoff RM (2007) Inflammatory cell migration into the central nervous system: a few new twists on an old tale. Brain Pathol 17:243\u2013250. doi:\n                    10.1111\/j.1750-3639.2007.00067.x","journal-title":"Brain Pathol"},{"key":"1466_CR79","first-page":"1573","volume":"60","author":"V Manolov","year":"2014","unstructured":"Manolov V, Petrova I, Vasilev V (2014) VEGF levels in diagnosis of vasculitic neuropathy. Clin Lab 60:1573\u20131577","journal-title":"Clin Lab"},{"key":"1466_CR80","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2014-309697","author":"EK Mathey","year":"2015","unstructured":"Mathey EK, Park SB, Hughes RA, Pollard JD, Armati PJ, Barnett MH, Taylor BV, Dyck PJ, Kiernan MC, Lin CS (2015) Chronic inflammatory demyelinating polyradiculoneuropathy: from pathology to phenotype. J Neurol Neurosurg Psychiatry. doi:\n                    10.1136\/jnnp-2014-309697","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1466_CR81","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0022-510X(99)00009-X","volume":"163","author":"EK Mathey","year":"1999","unstructured":"Mathey EK, Pollard JD, Armati PJ (1999) TNF alpha, IFN gamma and IL-2 mRNA expression in CIDP sural nerve biopsies. J Neurol Sci 163:47\u201352","journal-title":"J Neurol Sci"},{"key":"1466_CR82","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/0022-510X(94)90070-1","volume":"127","author":"K Matsumuro","year":"1994","unstructured":"Matsumuro K, Izumo S, Umehara F, Osame M (1994) Chronic inflammatory demyelinating polyneuropathy: histological and immunopathological studies on biopsied sural nerves. J Neurol Sci 127:170\u2013178","journal-title":"J Neurol Sci"},{"key":"1466_CR83","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2990.1992.tb00778.x","volume":"18","author":"PA McCombe","year":"1992","unstructured":"McCombe PA, van der Kreek SA, Pender MP (1992) Neuropathological findings in chronic relapsing experimental allergic neuritis induced in the Lewis rat by inoculation with intradural root myelin and treatment with low dose cyclosporin A. Neuropathol Appl Neurobiol 18:171\u2013187","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1466_CR84","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.jns.2004.10.001","volume":"228","author":"FJ Mei","year":"2005","unstructured":"Mei FJ, Ishizu T, Murai H, Osoegawa M, Minohara M, Zhang KN, Kira J (2005) Th1 shift in CIDP versus Th2 shift in vasculitic neuropathy in CSF. J Neurol Sci 228:75\u201385. doi:\n                    10.1016\/j.jns.2004.10.001","journal-title":"J Neurol Sci"},{"key":"1466_CR85","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/S0165-5728(96)00189-0","volume":"73","author":"C Melendez-Vasquez","year":"1997","unstructured":"Melendez-Vasquez C, Redford J, Choudhary PP, Gray IA, Maitland P, Gregson NA, Smith KJ, Hughes RA (1997) Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 73:124\u2013134","journal-title":"J Neuroimmunol"},{"key":"1466_CR86","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1038\/ncpneuro0452","volume":"3","author":"G Meyer zu Horste","year":"2007","unstructured":"Meyer zu Horste G, Hartung HP, Kieseier BC (2007) From bench to bedside\u2013experimental rationale for immune-specific therapies in the inflamed peripheral nerve. Nat Clin Pract Neurol 3:198\u2013211. doi:\n                    10.1038\/ncpneuro0452","journal-title":"Nat Clin Pract Neurol"},{"key":"1466_CR87","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/mus.21325","volume":"40","author":"G Meyer zu Horste","year":"2009","unstructured":"Meyer zu Horste G, Reiners J, Lehmann HC, Airas L, Kieseier BC (2009) CD73 is expressed on invading T lymphocytes in the inflamed peripheral nerve. Muscle Nerve 40:287\u2013289. doi:\n                    10.1002\/mus.21325","journal-title":"Muscle Nerve"},{"key":"1466_CR88","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/0022-510X(91)90065-F","volume":"102","author":"GW Mitchell","year":"1991","unstructured":"Mitchell GW, Williams GS, Bosch EP, Hart MN (1991) Class II antigen expression in peripheral neuropathies. J Neurol Sci 102:170\u2013176","journal-title":"J Neurol Sci"},{"key":"1466_CR89","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.neuroscience.2004.06.083","volume":"129","author":"N Mitsuma","year":"2004","unstructured":"Mitsuma N, Yamamoto M, Iijima M, Hattori N, Ito Y, Tanaka F, Sobue G (2004) Wide range of lineages of cells expressing nerve growth factor mRNA in the nerve lesions of patients with vasculitic neuropathy: an implication of endoneurial macrophage for nerve regeneration. Neuroscience 129:109\u2013117. doi:\n                    10.1016\/j.neuroscience.2004.06.083","journal-title":"Neuroscience"},{"issue":"Suppl 2","key":"1466_CR90","doi-asserted-by":"publisher","first-page":"S180","DOI":"10.1086\/513786","volume":"176","author":"DS Monos","year":"1997","unstructured":"Monos DS, Papaioakim M, Ho TW, Li CY, McKhann GM (1997) Differential distribution of HLA alleles in two forms of Guillain\u2013Barre syndrome. J Infect Dis 176(Suppl 2):S180\u2013S182","journal-title":"J Infect Dis"},{"key":"1466_CR91","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.transci.2013.07.024","volume":"49","author":"M Mrad","year":"2013","unstructured":"Mrad M, Fekih-Mrissa N, Mansour M, Seyah A, Riahi A, Gritli N, Mrissa R (2013) Association of HLA-DR\/DQ polymorphism with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) in Tunisian patients. Transfus Apher Science 49:623\u2013626. doi:\n                    10.1016\/j.transci.2013.07.024","journal-title":"Transfus Apher Science"},{"key":"1466_CR92","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1097\/01.jnen.0000229239.43866.d1","volume":"65","author":"M Muller","year":"2006","unstructured":"Muller M, Stenner M, Wacker K, Ringelstein EB, Hickey WF, Kiefer R (2006) Contribution of resident endoneurial macrophages to the local cellular response in experimental autoimmune neuritis. J Neuropathol Exp Neurol 65:499\u2013507. doi:\n                    10.1097\/01.jnen.0000229239.43866.d1","journal-title":"J Neuropathol Exp Neurol"},{"key":"1466_CR93","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/BF02339236","volume":"15","author":"AM Musso","year":"1994","unstructured":"Musso AM, Zanusso GL, Bonazzi ML, Tomelleri G, Bonetti B, Moretto G, Vio M, Monaco S (1994) Increased serum levels of ICAM-1, ELAM-1 and TNF-alpha in inflammatory disorders of the peripheral nervous system. Ital J Neurol Sci 15:267\u2013271","journal-title":"Ital J Neurol Sci"},{"key":"1466_CR94","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1212\/WNL.55.12.1828","volume":"55","author":"A Nagai","year":"2000","unstructured":"Nagai A, Murakawa Y, Terashima M, Shimode K, Umegae N, Takeuchi H, Kobayashi S (2000) Cystatin C and cathepsin B in CSF from patients with inflammatory neurologic diseases. Neurology 55:1828\u20131832","journal-title":"Neurology"},{"key":"1466_CR95","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1212\/01.WNL.0000081049.14098.50","volume":"61","author":"S Nishino","year":"2003","unstructured":"Nishino S, Kanbayashi T, Fujiki N, Uchino M, Ripley B, Watanabe M, Lammers GJ, Ishiguro H, Shoji S, Nishida Y, Overeem S, Toyoshima I, Yoshida Y, Shimizu T, Taheri S, Mignot E (2003) CSF hypocretin levels in Guillain\u2013Barre syndrome and other inflammatory neuropathies. Neurology 61:823\u2013825","journal-title":"Neurology"},{"key":"1466_CR96","doi-asserted-by":"publisher","first-page":"3540","DOI":"10.1002\/jnr.22514","volume":"88","author":"KK Nyati","year":"2010","unstructured":"Nyati KK, Prasad KN, Verma A, Paliwal VK (2010) Correlation of matrix metalloproteinases-2 and -9 with proinflammatory cytokines in Guillain\u2013Barre syndrome. J Neurosci Res 88:3540\u20133546. doi:\n                    10.1002\/jnr.22514","journal-title":"J Neurosci Res"},{"issue":"Suppl","key":"1466_CR97","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/ana.410090713","volume":"9","author":"H Nyland","year":"1981","unstructured":"Nyland H, Matre R, Mork S (1981) Immunological characterization of sural nerve biopsies from patients with Guillain\u2013Barre syndrome. Ann Neurol 9(Suppl):80\u201386","journal-title":"Ann Neurol"},{"key":"1466_CR98","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1212\/WNL.44.5.946","volume":"44","author":"N Oka","year":"1994","unstructured":"Oka N, Akiguchi I, Nagao M, Nishio T, Kawasaki T, Kimura J (1994) Expression of endothelial leukocyte adhesion molecule-1 (ELAM-1) in chronic inflammatory demyelinating polyneuropathy. Neurology 44:946\u2013950","journal-title":"Neurology"},{"key":"1466_CR99","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1111\/j.1440-1789.2007.00817.x","volume":"27","author":"N Oka","year":"2007","unstructured":"Oka N, Kawasaki T, Mizutani K, Sugiyama H, Akiguchi I (2007) Hypoxia-inducible factor 1alpha may be a marker for vasculitic neuropathy. Neuropathology 27:509\u2013515. doi:\n                    10.1111\/j.1440-1789.2007.00817.x","journal-title":"Neuropathology"},{"key":"1466_CR100","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/mus.880141013","volume":"14","author":"PG Oomes","year":"1991","unstructured":"Oomes PG, van der Meche FG, Markus-Silvis L, Meulstee J, Kleyweg RP (1991) In vivo effects of sera from Guillain\u2013Barre subgroups: an electrophysiological and histological study on rat nerves. Muscle Nerve 14:1013\u20131020. doi:\n                    10.1002\/mus.880141013","journal-title":"Muscle Nerve"},{"key":"1466_CR101","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/S0165-5728(02)00393-4","volume":"134","author":"D Orlikowski","year":"2003","unstructured":"Orlikowski D, Chazaud B, Plonquet A, Poron F, Sharshar T, Maison P, Raphael JC, Gherardi RK, Creange A (2003) Monocyte chemoattractant protein 1 and chemokine receptor CCR2 productions in Guillain-Barre syndrome and experimental autoimmune neuritis. J Neuroimmunol 134:118\u2013127","journal-title":"J Neuroimmunol"},{"key":"1466_CR102","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/mus.21239","volume":"40","author":"A Petzold","year":"2009","unstructured":"Petzold A, Brettschneider J, Jin K, Keir G, Murray NM, Hirsch NP, Itoyama Y, Reilly MM, Takeda A, Tumani H (2009) CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain\u2013Barre syndrome. Muscle Nerve 40:42\u201349. doi:\n                    10.1002\/mus.21239","journal-title":"Muscle Nerve"},{"key":"1466_CR103","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/ana.410210404","volume":"21","author":"JD Pollard","year":"1987","unstructured":"Pollard JD, Baverstock J, McLeod JG (1987) Class II antigen expression and inflammatory cells in the Guillain\u2013Barre syndrome. Ann Neurol 21:337\u2013341. doi:\n                    10.1002\/ana.410210404","journal-title":"Ann Neurol"},{"key":"1466_CR104","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/0165-5728(86)90059-7","volume":"13","author":"JD Pollard","year":"1986","unstructured":"Pollard JD, McCombe PA, Baverstock J, Gatenby PA, McLeod JG (1986) Class II antigen expression and T lymphocyte subsets in chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 13:123\u2013134","journal-title":"J Neuroimmunol"},{"key":"1466_CR105","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.jneuroim.2004.09.020","volume":"159","author":"R Press","year":"2005","unstructured":"Press R, Nennesmo I, Kouwenhoven M, Huang YM, Link H, Pashenkov M (2005) Dendritic cells in the cerebrospinal fluid and peripheral nerves in Guillain\u2013Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol 159:165\u2013176. doi:\n                    10.1016\/j.jneuroim.2004.09.020","journal-title":"J Neuroimmunol"},{"key":"1466_CR106","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1023\/A:1024532715775","volume":"23","author":"R Press","year":"2003","unstructured":"Press R, Pashenkov M, Jin JP, Link H (2003) Aberrated levels of cerebrospinal fluid chemokines in Guillain\u2013Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Clin Immunol 23:259\u2013267","journal-title":"J Clin Immunol"},{"key":"1466_CR107","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1002\/ana.410440406","volume":"44","author":"SC Previtali","year":"1998","unstructured":"Previtali SC, Archelos JJ, Hartung HP (1998) Expression of integrins in experimental autoimmune neuritis and Guillain\u2013Barre syndrome. Ann Neurol 44:611\u2013621. doi:\n                    10.1002\/ana.410440406","journal-title":"Ann Neurol"},{"issue":"Suppl","key":"1466_CR108","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1002\/ana.410090704","volume":"9","author":"JW Prineas","year":"1981","unstructured":"Prineas JW (1981) Pathology of the Guillain\u2013Barre syndrome. Ann Neurol 9(Suppl):6\u201319","journal-title":"Ann Neurol"},{"key":"1466_CR109","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.nmd.2010.01.005","volume":"20","author":"S Probst-Cousin","year":"2010","unstructured":"Probst-Cousin S, Neundorfer B, Heuss D (2010) Microvasculopathic neuromuscular diseases: lessons from hypoxia-inducible factors. Neuromuscul Disord 20:192\u2013197. doi:\n                    10.1016\/j.nmd.2010.01.005","journal-title":"Neuromuscul Disord"},{"key":"1466_CR110","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/S0022-510X(99)00328-7","volume":"174","author":"GA Putzu","year":"2000","unstructured":"Putzu GA, Figarella-Branger D, Bouvier-Labit C, Liprandi A, Bianco N, Pellissier JF (2000) Immunohistochemical localization of cytokines, C5b-9 and ICAM-1 in peripheral nerve of Guillain\u2013Barre syndrome. J Neurol Sci 174:16\u201321","journal-title":"J Neurol Sci"},{"key":"1466_CR111","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0165-5728(95)00102-8","volume":"62","author":"JH Rees","year":"1995","unstructured":"Rees JH, Vaughan RW, Kondeatis E, Hughes RA (1995) HLA-class II alleles in Guillain-Barre syndrome and Miller Fisher syndrome and their association with preceding Campylobacter jejuni infection. J Neuroimmunol 62:53\u201357","journal-title":"J Neuroimmunol"},{"key":"1466_CR112","doi-asserted-by":"publisher","first-page":"R107","DOI":"10.1186\/ar3388","volume":"13","author":"A Regent","year":"2011","unstructured":"Regent A, Dib H, Ly KH, Agard C, Tamby MC, Tamas N, Weksler B, Federici C, Broussard C, Guillevin L, Mouthon L (2011) Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach. Arthritis Res Ther 13:R107. doi:\n                    10.1186\/ar3388","journal-title":"Arthritis Res Ther"},{"key":"1466_CR113","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.clim.2014.03.020","volume":"153","author":"A Regent","year":"2014","unstructured":"Regent A, Lofek S, Dib H, Bussone G, Tamas N, Federici C, Broussard C, Guillevin L, Mouthon L (2014) Identification of target antigens of anti-endothelial cell antibodies in patients with anti-neutrophil cytoplasmic antibody-associated vasculitides: a proteomic approach. Clin Immunol 153:123\u2013135. doi:\n                    10.1016\/j.clim.2014.03.020","journal-title":"Clin Immunol"},{"key":"1466_CR114","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/jns5.12020","volume":"18","author":"S Rinaldi","year":"2013","unstructured":"Rinaldi S (2013) Update on Guillain\u2013Barre syndrome. J Peripher Nerv Syst 18:99\u2013112. doi:\n                    10.1111\/jns5.12020","journal-title":"J Peripher Nerv Syst"},{"key":"1466_CR115","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s004010050941","volume":"96","author":"N Rizzuto","year":"1998","unstructured":"Rizzuto N, Morbin M, Cavallaro T, Ferrari S, Fallahi M, Galiazzo Rizzuto S (1998) Focal lesions area feature of chronic inflammatory demyelinating polyneuropathy (CIDP). Acta Neuropathol 96:603\u2013609","journal-title":"Acta Neuropathol"},{"key":"1466_CR116","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/ana.410110112","volume":"11","author":"T Saida","year":"1982","unstructured":"Saida T, Saida K, Lisak RP, Brown MJ, Silberberg DH, Asbury AK (1982) In vivo demyelinating activity of sera from patients with Guillain\u2013Barre syndrome. Ann Neurol 11:69\u201375. doi:\n                    10.1002\/ana.410110112","journal-title":"Ann Neurol"},{"key":"1466_CR117","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.cyto.2010.05.005","volume":"51","author":"PP Sainaghi","year":"2010","unstructured":"Sainaghi PP, Collimedaglia L, Alciato F, Leone MA, Naldi P, Molinari R, Monaco F, Avanzi GC (2010) The expression pattern of inflammatory mediators in cerebrospinal fluid differentiates Guillain\u2013Barre syndrome from chronic inflammatory demyelinating polyneuropathy. Cytokine 51:138\u2013143. doi:\n                    10.1016\/j.cyto.2010.05.005","journal-title":"Cytokine"},{"key":"1466_CR118","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.jns.2008.01.005","volume":"269","author":"PP Sainaghi","year":"2008","unstructured":"Sainaghi PP, Collimedaglia L, Alciato F, Leone MA, Puta E, Naldi P, Castello L, Monaco F, Avanzi GC (2008) Elevation of Gas6 protein concentration in cerebrospinal fluid of patients with chronic inflammatory demyelinating polyneuropathy (CIDP). J Neurol Sci 269:138\u2013142. doi:\n                    10.1016\/j.jns.2008.01.005","journal-title":"J Neurol Sci"},{"key":"1466_CR119","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1084\/jem.194.5.677","volume":"194","author":"B Salomon","year":"2001","unstructured":"Salomon B, Rhee L, Bour-Jordan H, Hsin H, Montag A, Soliven B, Arcella J, Girvin AM, Padilla J, Miller SD, Bluestone JA (2001) Development of spontaneous autoimmune peripheral polyneuropathy in B7-2-deficient NOD mice. J Exp Med 194:677\u2013684","journal-title":"J Exp Med"},{"key":"1466_CR120","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1080\/00207450801898220","volume":"118","author":"L Sarikcioglu","year":"2008","unstructured":"Sarikcioglu L, Demirel BM, Demir N, Yildirim FB, Demirtop A, Oguz N (2008) Morphological and ultrastructural analysis of the watershed zones after stripping of the vasa nervorum. Int J Neurosci 118:1145\u20131155. doi:\n                    10.1080\/00207450801898220","journal-title":"Int J Neurosci"},{"key":"1466_CR121","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<474::AID-MUS8>3.0.CO;2-9","volume":"19","author":"B Schmidt","year":"1996","unstructured":"Schmidt B, Toyka KV, Kiefer R, Full J, Hartung HP, Pollard J (1996) Inflammatory infiltrates in sural nerve biopsies in Guillain\u2013Barre syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve 19:474\u2013487. doi:\n                    10.1002\/(SICI)1097-4598(199604)19:4<474:AID-MUS8>3.0.CO;2-9","journal-title":"Muscle Nerve"},{"key":"1466_CR122","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0165-5728(97)00143-4","volume":"80","author":"G Sessa","year":"1997","unstructured":"Sessa G, Nemni R, Canal N, Marchisio PC (1997) Circulating fragments of myelin-associated alpha 6 beta 4 integrin in Guillain\u2013Barre syndrome. J Neuroimmunol 80:115\u2013120","journal-title":"J Neuroimmunol"},{"key":"1466_CR123","doi-asserted-by":"publisher","first-page":"e104205","DOI":"10.1371\/journal.pone.0104205","volume":"9","author":"F Shimizu","year":"2014","unstructured":"Shimizu F, Sawai S, Sano Y, Beppu M, Misawa S, Nishihara H, Koga M, Kuwabara S, Kanda T (2014) Severity and patterns of blood\u2013nerve barrier breakdown in patients with chronic inflammatory demyelinating polyradiculoneuropathy: correlations with clinical subtypes. PLoS One 9:e104205. doi:\n                    10.1371\/journal.pone.0104205","journal-title":"PLoS One"},{"key":"1466_CR124","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1093\/ilar\/ilt054","volume":"54","author":"B Soliven","year":"2014","unstructured":"Soliven B (2014) Animal models of autoimmune neuropathy. ILAR J 54:282\u2013290. doi:\n                    10.1093\/ilar\/ilt054","journal-title":"ILAR J"},{"issue":"Suppl 1","key":"1466_CR125","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1529-8027.2011.00301.x","volume":"16","author":"C Sommer","year":"2011","unstructured":"Sommer C, Toyka K (2011) Nerve biopsy in chronic inflammatory neuropathies: in situ biomarkers. J Peripher Nerv Syst 16(Suppl 1):24\u201329. doi:\n                    10.1111\/j.1529-8027.2011.00301.x","journal-title":"J Peripher Nerv Syst"},{"issue":"Suppl 1","key":"1466_CR126","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1111\/j.1529-8027.2011.00302.x","volume":"16","author":"AJ Steck","year":"2011","unstructured":"Steck AJ, Kinter J, Renaud S (2011) Differential gene expression in nerve biopsies of inflammatory neuropathies. J Peripher Nerv Syst 16(Suppl 1):30\u201333. doi:\n                    10.1111\/j.1529-8027.2011.00302.x","journal-title":"J Peripher Nerv Syst"},{"key":"1466_CR127","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00687376","volume":"77","author":"A Stevens","year":"1989","unstructured":"Stevens A, Schabet M, Schott K, Wietholter H (1989) Role of endoneural cells in experimental allergic neuritis and characterisation of a resident phagocytic cell. Acta Neuropathol 77:412\u2013419","journal-title":"Acta Neuropathol"},{"key":"1466_CR128","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1111\/j.1600-0404.1985.tb03214.x","volume":"71","author":"A Suzumura","year":"1985","unstructured":"Suzumura A, Sobue G, Sugimura K, Matsuoka Y, Sobue I (1985) Chronic experimental allergic neuritis (EAN) in juvenile guinea pigs: immunological comparison with acute EAN in adult guinea pigs. Acta Neurol Scand 71:364\u2013372","journal-title":"Acta Neurol Scand"},{"key":"1466_CR129","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1055\/s-0033-1334470","volume":"32","author":"JW Teener","year":"2012","unstructured":"Teener JW (2012) Miller Fisher\u2019s syndrome. Semin Neurol 32:512\u2013516. doi:\n                    10.1055\/s-0033-1334470","journal-title":"Semin Neurol"},{"key":"1466_CR130","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.jneuroim.2009.06.012","volume":"214","author":"H Tumani","year":"2009","unstructured":"Tumani H, Pfeifle M, Lehmensiek V, Rau D, Mogel H, Ludolph AC, Brettschneider J (2009) Candidate biomarkers of chronic inflammatory demyelinating polyneuropathy (CIDP): proteome analysis of cerebrospinal fluid. J Neuroimmunol 214:109\u2013112. doi:\n                    10.1016\/j.jneuroim.2009.06.012","journal-title":"J Neuroimmunol"},{"key":"1466_CR131","doi-asserted-by":"publisher","first-page":"141","DOI":"10.2174\/187153011795564124","volume":"11","author":"EE Ubogu","year":"2011","unstructured":"Ubogu EE (2011) Chemokine receptors as specific anti-inflammatory targets in peripheral nerves. Endocr Metab Immune Disord Drug Targets 11:141\u2013153","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"1466_CR132","doi-asserted-by":"publisher","first-page":"373","DOI":"10.2478\/s13380-012-0039-4","volume":"3","author":"EE Ubogu","year":"2012","unstructured":"Ubogu EE (2012) Translational strategies in peripheral neuroinflammation and neurovascular repair. Transl Neurosci 3:373\u2013383. doi:\n                    10.2478\/s13380-012-0039-4","journal-title":"Transl Neurosci"},{"key":"1466_CR133","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/978-1-62703-426-5_2","volume":"1013","author":"EE Ubogu","year":"2013","unstructured":"Ubogu EE (2013) Chemokine-dependent signaling pathways in the peripheral nervous system. Methods Mol Biol 1013:17\u201330. doi:\n                    10.1007\/978-1-62703-426-5_2","journal-title":"Methods Mol Biol"},{"key":"1466_CR134","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1159\/000353293","volume":"50","author":"EE Ubogu","year":"2013","unstructured":"Ubogu EE (2013) The molecular and biophysical characterization of the human blood\u2013nerve barrier: current concepts. J Vasc Res 50:289\u2013303. doi:\n                    10.1159\/000353293","journal-title":"J Vasc Res"},{"key":"1466_CR135","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1529-8027.2012.00375.x","volume":"17","author":"EE Ubogu","year":"2012","unstructured":"Ubogu EE, Yosef N, Xia RH, Sheikh KA (2012) Behavioral, electrophysiological, and histopathological characterization of a severe murine chronic demyelinating polyneuritis model. J Peripher Nerv Syst 17:53\u201361. doi:\n                    10.1111\/j.1529-8027.2012.00375.x","journal-title":"J Peripher Nerv Syst"},{"key":"1466_CR136","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s00401-010-0662-5","volume":"120","author":"N Uceyler","year":"2010","unstructured":"Uceyler N, Devigili G, Toyka KV, Sommer C (2010) Skin biopsy as an additional diagnostic tool in non-systemic vasculitic neuropathy. Acta Neuropathol 120:109\u2013116. doi:\n                    10.1007\/s00401-010-0662-5","journal-title":"Acta Neuropathol"},{"key":"1466_CR137","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1038\/nrneurol.2014.121","volume":"10","author":"B van den Berg","year":"2014","unstructured":"van den Berg B, Walgaard C, Drenthen J, Fokke C, Jacobs BC, van Doorn PA (2014) Guillain-Barre syndrome: pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 10:469\u2013482. doi:\n                    10.1038\/nrneurol.2014.121","journal-title":"Nat Rev Neurol"},{"key":"1466_CR138","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/0022-510X(94)90142-2","volume":"127","author":"LH van den Berg","year":"1994","unstructured":"van den Berg LH, Oey PL, Wokke JH, Veldman H, Wieneke GH, Notermans SH (1994) Features of the Guillain\u2013Barre syndrome in mice following intraperitoneal injection of patient serum. J Neurol Sci 127:103\u2013106","journal-title":"J Neurol Sci"},{"key":"1466_CR139","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0165-5728(91)90005-R","volume":"32","author":"PA van Doorn","year":"1991","unstructured":"van Doorn PA, Schreuder GM, Vermeulen M, d\u2019Amaro J, Brand A (1991) HLA antigens in patients with chronic inflammatory demyelinating polyneuropathy. J Neuroimmunol 32:133\u2013139","journal-title":"J Neuroimmunol"},{"issue":"Pt 10","key":"1466_CR140","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1093\/brain\/123.10.2020","volume":"123","author":"I Van Rhijn","year":"2000","unstructured":"Van Rhijn I, Van den Berg LH, Bosboom WM, Otten HG, Logtenberg T (2000) Expression of accessory molecules for T-cell activation in peripheral nerve of patients with CIDP and vasculitic neuropathy. Brain 123(Pt 10):2020\u20132029","journal-title":"Brain"},{"key":"1466_CR141","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1111\/j.1600-0404.1988.tb03676.x","volume":"78","author":"CA Vedeler","year":"1988","unstructured":"Vedeler CA, Matre R, Nyland H (1988) Class and IgG subclass distribution of antibodies against peripheral nerve myelin in sera from patients with inflammatory demyelinating polyradiculoneuropathy. Acta Neurol Scand 78:401\u2013407","journal-title":"Acta Neurol Scand"},{"key":"1466_CR142","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1111\/j.1468-1331.2010.03041.x","volume":"18","author":"AF Vrancken","year":"2011","unstructured":"Vrancken AF, Gathier CS, Cats EA, Notermans NC, Collins MP (2011) The additional yield of combined nerve\/muscle biopsy in vasculitic neuropathy. Eur J Neurol 18:49\u201358. doi:\n                    10.1111\/j.1468-1331.2010.03041.x","journal-title":"Eur J Neurol"},{"key":"1466_CR143","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrneurol.2014.138","volume":"10","author":"BR Wakerley","year":"2014","unstructured":"Wakerley BR, Uncini A, Yuki N, Group GBSC, Group GBSC (2014) Guillain-Barre and Miller Fisher syndromes\u2014new diagnostic classification. Nat Rev Neurol 10:537\u2013544. doi:\n                    10.1038\/nrneurol.2014.138","journal-title":"Nat Rev Neurol"},{"key":"1466_CR144","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s10072-012-1092-z","volume":"34","author":"XK Wang","year":"2013","unstructured":"Wang XK, Zhang HL, Meng FH, Chang M, Wang YZ, Jin T, Mix E, Zhu J (2013) Elevated levels of S100B, tau and pNFH in cerebrospinal fluid are correlated with subtypes of Guillain\u2013Barre syndrome. Neurol Sci 34:655\u2013661. doi:\n                    10.1007\/s10072-012-1092-z","journal-title":"Neurol Sci"},{"key":"1466_CR145","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1046\/j.1468-1331.1999.640499.x","volume":"6","author":"JM Wilmshurst","year":"1999","unstructured":"Wilmshurst JM, Pohl KR, Vaughan RW, Hughes RA (1999) Familial Guillain\u2013Barre syndrome. Eur J Neurol 6:499\u2013503","journal-title":"Eur J Neurol"},{"key":"1466_CR146","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1007\/s004150200072","volume":"249","author":"J Winer","year":"2002","unstructured":"Winer J, Hughes S, Cooper J, Ben-Smith A, Savage C (2002) gamma delta T cells infiltrating sensory nerve biopsies from patients with inflammatory neuropathy. J Neurol 249:616\u2013621. doi:\n                    10.1007\/s004150200072","journal-title":"J Neurol"},{"key":"1466_CR147","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jneuroim.2010.09.017","volume":"231","author":"JB Winer","year":"2011","unstructured":"Winer JB (2011) Guillain\u2013Barre syndrome: clinical variants and their pathogenesis. J Neuroimmunol 231:70\u201372. doi:\n                    10.1016\/j.jneuroim.2010.09.017","journal-title":"J Neuroimmunol"},{"key":"1466_CR148","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1111\/j.1365-2990.2010.01092.x","volume":"36","author":"RH Xia","year":"2010","unstructured":"Xia RH, Yosef N, Ubogu EE (2010) Selective expression and cellular localization of pro-inflammatory chemokine ligand\/receptor pairs in the sciatic nerves of a severe murine experimental autoimmune neuritis model of Guillain\u2013Barre syndrome. Neuropathol Appl Neurobiol 36:388\u2013398. doi:\n                    10.1111\/j.1365-2990.2010.01092.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1466_CR149","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1038\/mt.2014.77","volume":"22","author":"ME Yalvac","year":"2014","unstructured":"Yalvac ME, Arnold WD, Hussain SR, Braganza C, Shontz KM, Clark KR, Walker CM, Ubogu EE, Mendell JR, Sahenk Z (2014) VIP-expressing dendritic cells protect against spontaneous autoimmune peripheral polyneuropathy. Mol Ther 22:1353\u20131363. doi:\n                    10.1038\/mt.2014.77","journal-title":"Mol Ther"},{"key":"1466_CR150","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1002\/mus.1077","volume":"24","author":"M Yamamoto","year":"2001","unstructured":"Yamamoto M, Ito Y, Mitsuma N, Li M, Hattori N, Sobue G (2001) Pathology-related differential expression regulation of NGF, GDNF, CNTF, and IL-6 mRNAs in human vasculitic neuropathy. Muscle Nerve 24:830\u2013833","journal-title":"Muscle Nerve"},{"key":"1466_CR151","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/ana.1129","volume":"50","author":"WX Yan","year":"2001","unstructured":"Yan WX, Archelos JJ, Hartung HP, Pollard JD (2001) P0 protein is a target antigen in chronic inflammatory demyelinating polyradiculoneuropathy. Ann Neurol 50:286\u2013292","journal-title":"Ann Neurol"},{"key":"1466_CR152","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1002\/1531-8249(200006)47:6<765::AID-ANA9>3.0.CO;2-8","volume":"47","author":"WX Yan","year":"2000","unstructured":"Yan WX, Taylor J, Andrias-Kauba S, Pollard JD (2000) Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients. Ann Neurol 47:765\u2013775","journal-title":"Ann Neurol"},{"key":"1466_CR153","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1007\/s11033-008-9228-1","volume":"36","author":"Y Yang","year":"2009","unstructured":"Yang Y, Liu S, Qin Z, Cui Y, Qin Y, Bai S (2009) Alteration of cystatin C levels in cerebrospinal fluid of patients with Guillain\u2013Barre Syndrome by a proteomical approach. Mol Biol Rep 36:677\u2013682. doi:\n                    10.1007\/s11033-008-9228-1","journal-title":"Mol Biol Rep"},{"key":"1466_CR154","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s10571-007-9257-7","volume":"28","author":"YR Yang","year":"2008","unstructured":"Yang YR, Liu SL, Qin ZY, Liu FJ, Qin YJ, Bai SM, Chen ZY (2008) Comparative proteomics analysis of cerebrospinal fluid of patients with Guillain\u2013Barre syndrome. Cell Mol Neurobiol 28:737\u2013744. doi:\n                    10.1007\/s10571-007-9257-7","journal-title":"Cell Mol Neurobiol"},{"key":"1466_CR155","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1182\/blood-2006-05-026401","volume":"109","author":"K Yano","year":"2007","unstructured":"Yano K, Gale D, Massberg S, Cheruvu PK, Monahan-Earley R, Morgan ES, Haig D, von Andrian UH, Dvorak AM, Aird WC (2007) Phenotypic heterogeneity is an evolutionarily conserved feature of the endothelium. Blood 109:613\u2013615. doi:\n                    10.1182\/blood-2006-05-026401","journal-title":"Blood"},{"key":"1466_CR156","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.1002\/jcp.24100","volume":"227","author":"N Yosef","year":"2012","unstructured":"Yosef N, Ubogu EE (2012) alpha(M)beta(2)-integrin-intercellular adhesion molecule-1 interactions drive the flow-dependent trafficking of Guillain\u2013Barre syndrome patient derived mononuclear leukocytes at the blood\u2013nerve barrier in vitro. J Cell Physiol 227:3857\u20133875. doi:\n                    10.1002\/jcp.24100","journal-title":"J Cell Physiol"},{"key":"1466_CR157","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1097\/NEN.0b013e3181c84a9a","volume":"69","author":"N Yosef","year":"2010","unstructured":"Yosef N, Xia RH, Ubogu EE (2010) Development and characterization of a novel human in vitro blood\u2013nerve barrier model using primary endoneurial endothelial cells. J Neuropathol Exp Neurol 69:82\u201397. doi:\n                    10.1097\/NEN.0b013e3181c84a9a","journal-title":"J Neuropathol Exp Neurol"},{"key":"1466_CR158","doi-asserted-by":"publisher","first-page":"e90463","DOI":"10.1371\/journal.pone.0090463","volume":"9","author":"F Yuan","year":"2014","unstructured":"Yuan F, Yosef N, Lakshmana Reddy C, Huang A, Chiang SC, Tithi HR, Ubogu EE (2014) CCR2 gene deletion and pharmacologic blockade ameliorate a severe murine experimental autoimmune neuritis model of Guillain\u2013Barre syndrome. PLoS One 9:e90463. doi:\n                    10.1371\/journal.pone.0090463","journal-title":"PLoS One"},{"key":"1466_CR159","doi-asserted-by":"publisher","first-page":"2294","DOI":"10.1056\/NEJMra1114525","volume":"366","author":"N Yuki","year":"2012","unstructured":"Yuki N, Hartung HP (2012) Guillain\u2013Barre syndrome. N Engl J Med 366:2294\u20132304. doi:\n                    10.1056\/NEJMra1114525","journal-title":"N Engl J Med"},{"key":"1466_CR160","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1600-0404.2011.01511.x","volume":"125","author":"HL Zhang","year":"2012","unstructured":"Zhang HL, Zhang XM, Mao XJ, Deng H, Li HF, Press R, Fredrikson S, Zhu J (2012) Altered cerebrospinal fluid index of prealbumin, fibrinogen, and haptoglobin in patients with Guillain\u2013Barre syndrome and chronic inflammatory demyelinating polyneuropathy. Acta Neurol Scand 125:129\u2013135. doi:\n                    10.1111\/j.1600-0404.2011.01511.x","journal-title":"Acta Neurol Scand"},{"key":"1466_CR161","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/j.cytogfr.2013.05.005","volume":"24","author":"HL Zhang","year":"2013","unstructured":"Zhang HL, Zheng XY, Zhu J (2013) Th1\/Th2\/Th17\/Treg cytokines in Guillain\u2013Barre syndrome and experimental autoimmune neuritis. Cytokine Growth Factor Rev 24:443\u2013453. doi:\n                    10.1016\/j.cytogfr.2013.05.005","journal-title":"Cytokine Growth Factor Rev"},{"key":"1466_CR162","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/S0165-5728(99)00100-9","volume":"98","author":"LP Zou","year":"1999","unstructured":"Zou LP, Pelidou SH, Abbas N, Deretzi G, Mix E, Schaltzbeerg M, Winblad B, Zhu J (1999) Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis rats. J Neuroimmunol 98:168\u2013175","journal-title":"J Neuroimmunol"},{"key":"1466_CR163","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1212\/WNL.33.2.234","volume":"33","author":"B Zweiman","year":"1983","unstructured":"Zweiman B, Rostami A, Lisak RP, Moskovitz AR, Pleasure DE (1983) Immune reactions to P2 protein in human inflammatory demyelinative neuropathies. Neurology 33:234\u2013237","journal-title":"Neurology"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-015-1466-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00401-015-1466-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-015-1466-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-015-1466-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T12:38:47Z","timestamp":1589632727000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00401-015-1466-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,12]]},"references-count":163,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["1466"],"URL":"https:\/\/doi.org\/10.1007\/s00401-015-1466-4","relation":{},"ISSN":["0001-6322","1432-0533"],"issn-type":[{"value":"0001-6322","type":"print"},{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,12]]},"assertion":[{"value":"14 March 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2015","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 August 2015","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 August 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}